Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antisense Therapeutics. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108738321B details novel GalNAc phosphoramidites for oligonucleotide conjugates, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.